Eli Lilly and Company (NYSE:LLY) Shares Acquired by ... - ETF Daily News
23 hours ago · Eli Lilly and Company Stock Performance. LLY opened at $799.39 on Monday. Eli Lilly and Company has a 1-year low of $612.70 and a 1-year high of $972.53. The stock has a market cap of $758.87 ...
Lilly announces new $4.5 billion site - the Lilly Medicine Foundry
INDIANAPOLIS, Oct. 2, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced a $4.5 billion investment to create the Lilly Medicine Foundry, a new center for advanced manufacturing and drug development.
Lilly.com | Eli Lilly and Company
INDIANAPOLIS , Dec. 9, 2024 /PRNewswire/ -- Today, the board of directors of Eli Lilly and Company (NYSE: LLY) approved a new $15 billion share repurchase program. The company's prior $5 billion share repurchase program was completed in the fourth quarter of 2024.
Eli Lilly and Company (LLY) - Yahoo Finance
Get the latest Eli Lilly and Company (LLY) stock news and headlines to help you in your trading and investing decisions.
All News | Eli Lilly and Company
Lilly's latest press releases, stories, news resources and more.
News Release - Eli Lilly and Company
INDIANAPOLIS, May 24, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that it has more than doubled its investment in its Lebanon, Indiana, manufacturing site with a new $5.3 billion commitment, increasing the company's total investment in this site from $3.7 billion to $9 billion.
Eli Lilly and Company (LLY) Latest Press Releases & Corporate News …
Get the latest Eli Lilly and Company (LLY) stock news and headlines to help you in your trading and investing decisions.
Lilly hits record high after Mounjaro fuels forecast raise, rival data
Aug 8, 2023 · Eli Lilly on Tuesday raised its annual forecasts as demand for new diabetes drug Mounjaro surges ahead of a decision on its use as a weight-loss treatment, with shares soaring 18% to a record...
News Release - Eli Lilly and Company
Jul 8, 2024 · Morphic's lead program is a selective oral small molecule inhibitor of α4β7 integrin for the treatment of inflammatory bowel disease (IBD) that has the potential to improve outcomes and expand treatment options for patients.
Lilly.com | Eli Lilly and Company
Nov 19, 2024 · INDIANAPOLIS , Sept. 9, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the appointment of Lucas Montarce as executive vice president and chief financial officer (CFO) and member of the company's Executive Committee, effective immediately.